Yuskaitis, Christopher J.

Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics

Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research

Wnt/β-catenin signaling in development and cancerProtein Kinase Regulation and GTPase Signaling

Cited by 774

Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity

Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling

Neuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology Research

Cited by 240

Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential

Min, W. W., Yuskaitis, C. J., Yan, Q., Sikorski, C., Chen, S., Jope, R. S., & Bauchwitz, R. P. (2009) · Neuropharmacology

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 146

Assessing the landscape of STXBP1 -related disorders in 534 individuals

Xian, J., Parthasarathy, S., Ruggiero, S. M., Balagura, G., Fitch, E., Helbig, K., Gan, J., Ganesan, S., Kaufman, M. C., Ellis, C. A., et al. (2022) · Brain

Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders

Cited by 130

Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.

Yuskaitis, C. J., Beurel, E., & Jope, R. S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 79